Jan Hillert spends much of his time researching Multiple sclerosis, Genetics, Immunology, Internal medicine and Allele. His Multiple sclerosis study incorporates themes from Odds ratio, Central nervous system disease, Case-control study and Disease, Age of onset. In Immunology, he works on issues like CLEC16A, which are connected to CD226, Lymphocyte differentiation, Cellular immunity and Genetic architecture.
His research in Internal medicine intersects with topics in Endocrinology, Surgery and Pathology. Jan Hillert interconnects Molecular biology, Genome and Genotype in the investigation of issues within Allele. His Human leukocyte antigen research incorporates elements of Interleukin-7 receptor, Genome-wide association study, Linkage disequilibrium and Genetic association.
Multiple sclerosis, Immunology, Internal medicine, Genetics and Human leukocyte antigen are his primary areas of study. His Multiple sclerosis study also includes
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology. His Genetics research focuses on Gene, Haplotype, Allele, Genetic predisposition and Single-nucleotide polymorphism. His studies in Allele integrate themes in fields like Locus, Genetic association and Genotype.
Jan Hillert mainly investigates Multiple sclerosis, Internal medicine, Cohort study, Cohort and Disease. Multiple sclerosis is a subfield of Immunology that Jan Hillert studies. His work carried out in the field of Internal medicine brings together such families of science as Neurology, Oncology and Rituximab.
His biological study deals with issues like Disability pension, which deal with fields such as Pediatrics and Sick leave. His research integrates issues of Randomized controlled trial and Proportional hazards model in his study of Cohort. As a part of the same scientific study, Jan Hillert usually deals with the Disease, concentrating on Virus and frequently concerns with Haplotype, Etiology and Serology.
His primary areas of study are Multiple sclerosis, Internal medicine, Expanded Disability Status Scale, Cohort study and Neurology. His Multiple sclerosis research is included under the broader classification of Immunology. The study incorporates disciplines such as Endocrinology, Cognition and Oncology in addition to Internal medicine.
His work in Expanded Disability Status Scale tackles topics such as Retrospective cohort study which are related to areas like Cohort, Natural history and Population based cohort. While the research belongs to areas of Odds ratio, Jan Hillert spends his time largely on the problem of Logistic regression, intersecting his research to questions surrounding Genetic predisposition, vitamin D deficiency, Quality of life, Vitamin D and neurology and Physiology. Jan Hillert has researched Epstein–Barr virus in several fields, including Autoimmune disease, Human leukocyte antigen, Etiology and Haplotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Variants conferring risk of atrial fibrillation on chromosome 4q25
Daniel F Gudbjartsson;David O Arnar;Anna Helgadottir;Solveig Gretarsdottir.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis.
Nature Genetics (2013)
Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
R. H.S.R. Roxburgh;S. R. Seaman;T. Masterman;A. E. Hensiek.
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm
Anna Helgadottir;Gudmar Thorleifsson;Kristinn P Magnusson;Solveig Grétarsdottir.
Nature Genetics (2008)
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis
Frida Lundmark;Kristina Duvefelt;Ellen Iacobaeus;Ingrid Kockum.
Nature Genetics (2007)
HLA CLASS II-ASSOCIATED GENETIC SUSCEPTIBILITY IN MULTIPLE SCLEROSIS : A CRITICAL EVALUATION
Olle Olerup;Jan Hillert.
Tissue Antigens (1991)
Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation.
Vilmantas Giedraitis;Bing He;Wen-Xin Huang;Jan Hillert.
Journal of Neuroimmunology (2001)
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke.
Daniel F Gudbjartsson;Hilma Holm;Hilma Holm;Solveig Gretarsdottir;Gudmar Thorleifsson.
Nature Genetics (2009)
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
G. Comi;V. Martinelli;M. Rodegher;L. Moiola.
The Lancet (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: